Navigation Links
Study Advocates Use Of Oral Painkillers After Cesarean Section

A new study published in the American Journal of Obstetrics and Gynecology has advocated the use of oral pain medication like oxycodone and acetaminophen for pain relief// after a cesarean section. The researchers say that this appears to be a better option than patient-controlled morphine.

Using these drugs for pain relief in postcesarean pain "offers superior pain relief with fewer undesirable side effects such as nausea and drowsiness for patients and appears to be less expensive and more convenient for providers and hospitals," the researchers write. Currently morphine infusions are preferred, but these have a lost of side effects that can be safely avoided by using oral medications, said lead researcher Dr. Kathryn M. Davis, from the University of Massachusetts Medical School. The study tracked 93 patients and divided them into two groups to either receive oxycodone-acetaminophen or patient-controlled analgesia. In 24 hours patients were allowed to take a maximum of 12 tablets, while the other group was on morphine for 12 hours after which they received oral analgesia. Researchers found that patients on oral analgesia had less pain and less nausea than those on morphine. But there was no significant difference n the frequency of vomiting, intake of fluids or movement in both groups.
'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer

Post Your Comments:
(Date:11/27/2009)...cal, economic burdens, study predicts , ,...f people with diabetes in the United States is exp...y predicts. , That would bring the total by 203...p from 23.7 million today. , , At the same time,...iple, the study also warns, rising from an estimat...
(Date:11/27/2009)...rade; announced today that Spectrum Health (Grand ...prise orthopedic templating solution and its Traum... (PRWEB) November 27, 2009 -- Voyant Health...d Rapids, Michigan) has licensed its TraumaCad Ent...umaCad Extend workflow solution, to allow its orth...
(Date:11/27/2009)...facturers who use medical load cells at the heart ...y bringing in technology partner Flintec early in ...ve medical manufacturers are calling in Flintec lo...ects, ensuring that progress will not be constrain...dated technology. , (PRWE...
(Date:11/26/2009).../ -- With cold and flu season upon us, it,s more i...trol the spread of infections and avoid illness. ,...selves healthy, but to avoid transmitting illness ...certified in infection-control), nursing director ...ospital for Special Surgery (HSS) in Manhattan. ,...
(Date:11/26/2009)...ricans living with diabetes will nearly double, in... in 2034. Over the same period, spending on diabet... $336 billion, even with no increase in the preval...ty of Chicago report in the December issue of Dia... covered by Medicare will rise from 8.2 million to...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
... ones neighborhood are associated with greater ast...g to researchers in Vancouver, Canada. , Social e...t factor in asthma manifestations in youth, but fe...n, Ph.D., of the University of British Columbia, a...
...P, FACEP (E) Executive Director ...ept. 27 "During a press event,yesterday aimed at ... Child,Left Behind Act, President Bush stated that...on his desk. The bipartisan,legislation, a result ...
...e Help of a Registered Dietitian, SAN BERNARDINO,...ce a new program designed to broaden the company,s... called "Healthy Selections." (Photo: http://www...rogram will educate and encourage,customers to mak...
...O,Alan P. Spielman presented testimony Sept. 26 ab...agement and Drug Therapy Management standards to,a... on Executive,Departments and Administration. (LO...ulate the practice of pharmacy benefit management ...
...nown as avian influenza, is considered a major glo...es. While little had been known about the specifi...the virus, researchers at Beijing University, Colu...1 victims that shed light on the anatomic distribu...
...ia types, its,hard not to notice that Britney has ...m all indications, something is definitely going o..., a patient came in recently for a dental,cosmetic... that pile was ... you guessed it, "Britney Spears...
Other Medicine News:Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 2Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 3Health News:APHA Urges President Bush Not To Veto CHIP; 'We're Only One Signature Away from Protecting the Health of Our Children' 2Health News:Stater Bros. Introduces New 'Healthy Selections' Dietitian Program 2Health News:URAC CEO Testifies Before New Hampshire Legislators Regarding New URAC Standards for Pharmacy Benefit Management 2Health News:New research shows how H5N1 virus causes disease 2
(Date:11/25/2009)..., LOVELAND, Colo., Nov. 25 /PRNewswire-FirstCal...ing provider of advanced diagnostic and specialt...oday agreements with Roche Diagnostics Corporation...ed consumables for the veterinary market. ,,...0622/HESKALOGO ) ,, "Heska and Roche share the ...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-FirstCall.... Michael J. McKelvey, the Company,s President and...ice President and CFO, are scheduled to present at...nce at 1:30 PM EST on December 1, 2009 in New York...ss the presentation by visiting the Company,s corp...
(Date:11/25/2009)... BRIDGEWATER, N.J., Nov. 25 The FD... (etravirine) tablets, a non-nucleoside reverse tr...ly NNRTI specifically indicated for use in treatme...ic failure with HIV-1 strains resistant to an NNRT...itional approval is based on 48-week data from two...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Neogen Named to Fortunes List of Fastest Growing Companies 12961 1Neogen Named to Fortunes List of Fastest Growing Companies 12961 2Nick Jonas Joins with Washington Nationals to Support Children with Diatbetes 51244 1Nick Jonas Joins with Washington Nationals to Support Children with Diatbetes 51244 2Video 3A What Are Those Little Red Bumps 3F 51242 1Video 3A What Are Those Little Red Bumps 3F 51242 2Video 3A What Are Those Little Red Bumps 3F 51242 3
...IB1001, an Intravenous Recombinant Factor IX (rFIX...AGUNA NIGUEL, Calif., Feb. 12 Inspiration Biophar...of a Phase 1 clinical trial of IB1001, an intraven...control and prevention of hemorrhagic episodes in ...the market for therapies to treat this disorder is...
...EUSAPharma (formerly Cytogen) Posts Positive Phase...ith Velcade for the Treatment of Relapsed or Refra... Quadramet (153 Samarium-lexidronam) is a radi...ally bone cancer, and is used to treat pain caused...bone. Velcade (bortezomib) is approved for th...
Other Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results 2
Spatula suction coagulator
Monopolar connecting cord
... incorporate a layered design unique in the indust...prevent stray electrosurgical burns along the shaf...r capacitive coupling; a well-documented patient s...EM Instruments provides a neutral return path for ...
... incorporate a layered design unique in the indust...prevent stray electrosurgical burns along the shaf...r capacitive coupling; a well-documented patient s...EM Instruments provides a neutral return path for ...
Medicine Products: